ARNOLD, Lee Daniel,LI, Leping,FRANCIS, Samson,TURNER, William W. Jr.,HAYDAR, Simon Nicolas,BURES, Mark G.,RAI, Roopa
申请号：
CL2019002503
公开号：
CL2019002503A1
申请日:
2019.08.30
申请国别(地区):
CL
年份:
2020
代理人:
摘要：
The present disclosure provides, in part, cyclic sulfamide compounds, and pharmaceutical compositions thereof, useful as modulators of Hepatitis B (HBV) core protein, and methods of treating Hepatitis B (HBV) infection.COMPUESTO DE SULFAMIDA CÍCLICO Y MÉTODOS DE USO DE LOS MISMO.
